DOCSLIB.ORG

SMW Supplementum

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
SMW Supplementum SMW Established in 1871 Swiss Medical Weekly Formerly: Schweizerische Medizinische Wochenschrift Supplementum 214 An open access, online journal • www.smw.ch ad Swiss Med Wkly 2015;145 November 12, 2015 47th Annual Meeting of the Swiss Society of Nephrology (SGN-SSN) Basel (Switzerland), December 3–4, 2015 TABLE OF CONTENTS 1 S Oral Communications 2 OC 1 – OC 6 Clinical Nephrology / Hypertension / Mineral / Electrolytes 5 OC 7 – OC 12 Basic science / Genetics / Experimental Nephrology 7 OC 13 – OC 18 Hemodialysis / Peritoneal Dialysis 10 OC 19 – OC 24 Transplantation Poster Presentations 13 P 1 – P 37 Clinical Nephrology / Hypertension / Mineral / Electrolytes 26 P 38 – P 48 Basic science / Genetics / Experimental Nephrology 30 P 49 – P 69 Hemodialysis / Peritoneal Dialysis 39 P 70 – P 85 Transplantation Index of first authors 46 Listed in: © EMH Swiss Medical Publishers Ltd. Creative Commons summary: http:// Editorial board: Index Medicus / MEDLINE (EMH), 2015. The Swiss Medical Weekly creativecommons.org/ Prof. Adriano Aguzzi, Zurich (ed. in chief) Web of science is an open access publication of EMH. licenses/by-nc-nd/2.5/ch/deed.en_GB; Prof. Manuel Battegay, Basel Current Contents Accordingly, EMH grants to all users on full licence: Prof. Jean-Michel Dayer, Geneva Science Citation Index the basis of the Creative Commons license http://creativecommons.org/licenses/ Prof. Beat Müller, Aarau EMBASE “Attribution – Non commercial – No by-nc-nd/2.5/ch/legalcode.de Prof. André P. Perruchoud, Basel Derivative Works” for an unlimited pe- (senior editor) Guidelines for authors riod the right to copy, distribute, display, Prof. Ludwig von Segesser, Lausanne The Guidelines for authors are published All communications to: and perform the work as well as to make it Prof. Christian Seiler, Berne on our website www.smw.ch EMH Swiss Medical Publishers Ltd. publicly available on condition that (1) the Prof. Peter Suter, Genève (senior editor) Submission to this journal proceeds to- Swiss Medical Weekly work is clearly attributed to the author or tally on-line: www.smw.ch Farnsburgerstrassse 8 Head of publications licensor (2) the work is not used for com- CH-4132 Muttenz, Switzerland Natalie Marty, MD ([email protected]) mercial purposes and (3) the work is not Phone +41 61 467 85 55 altered, transformed, or built upon. Any Papers administrator Fax +41 61 467 85 56 use of the work for commercial purposes Gisela Wagner ([email protected]) [email protected] needs the explicit prior authorisation of ISSN printed version: 1424-7860 EMH on the basis of a written agreement. ISSN online version: 1424–3997 SWISS MEDICAL WEEKLY 2015;145 (SUPPL 214) WWW.SMW.CH ORAL COMMUNICATIONS – CLINICAL NEPHROLOGY / HYPERTENSION / MINERAL / ELECTROLYTES 2 S OC 01 OC 02 Dietary intake of phosphate stimulates renal salt Therapeutic efficacy and cost effectiveness of high absorptiOn and increases bloOd pressure (NCCR PrOject) cut-off dialyzers compared to cOnventional dialysis Arezoo Daryadel1, Nilufar Mohebbi2, Udo Schnitzbauer3, in patients with cast nephropathy Nicole Gehring1, Michael Föller4, Florian Lang4, Johannes Loffing5, Adriano Curti1, Albin Schwarz1, Yuki Tomonaga2, Patrice Ambühl1 Carsten Wagner3 1Institut für Nephrologie, Stadtspital Waid, Zürich; 2Institut für Sozial- 1Institute of Physiology, University of Zurich, Zurich; 2Division of und Präventivmedizin, Universität Zürich, Zürich 3 Nephrology, University Hospital Zurich, Zurich; Institute of Physiology, Background: Multiple myeloma (MM) associated renal failure in cast Zurich Centre for Integrative Human Physiology, University of Zurich, nephropathy results from tubular precipitates of free light chains (FLC). Zurich; 4Institute of Physiology, University of Tübingen, Germany; 5 High cut-off (HCO) dialysis filters are able to efficiently reduce FLC Institute of Anatomy, University of Zurich, Zurich concentrations in the serum and may improve renal recovery. However, Background: The thiazide-sensitive Na+-Cl– cotransporter NCC is clinical trials which directly compare HCO dialyzers with conventional critical for renal salt reabsorption and blood pressure control. dialysis in cast nephropathy are lacking. The aim of this study was to High intake of dietary phosphate has been linked to increased assess clinical outcomes and economic impact of treatment with HCO cardiovascular morbidity and mortality in healthy subjects and patients dialyzers compared to conventional hemodialysis membranes in with kidney diseases. We examined the regulation of NCC by dietary patients with cast nephropathy. phosphate intake. Methods: Multicenter retrospective analysis of patients treated for Methods: Mice were kept for 1–5 days on low (0.1%) or high (1.2%) renal failure from FLC associated cast nephropathy after July 2005 phosphate (Pi) diets or received an acute bolus of phosphate by with a follow-up until September 2014. Treatment consisted of gavage. Plasma PTH, FGF23 and urinary aldosterone level were Bortezomib and Dexamethasone in all patients, and hemodialysis with measured by ELISA. Systolic blood pressure was monitored by the either HCO (n = 12) or conventional dialyzers (n = 7). tail cuff method. NCC abundance/phosphorylation was analyzed by Results: At the end of follow-up, 4 patients treated with HCO dialyzers western blot. Blood pressure in rats on high and low phosphate diets were still alive, while all patients in the control group had died (p = NS was measured by Telemetry. for Cox regression adjusted for age). With regard to recovery of renal Results: The high Pi diet increased plasma FGF23, PTH, urinary function, a non-significant trend to higher independence of dialysis aldosterone and renal renin expression. Systolic blood pressure was was seen in patients treated with HCO dialyzers. Moreover, trends elevated by high Pi diet and this effect was blunted by thiazide towards better renal function at 12 months after diagnosis of MM as diuretics. Thiazide diuretics on high Pi diet increased urinary NaCl well as lesser time on renal replacement therapy were noted in the excretion more than on low Pi diet. Phosphate increased NCC HCO group. Total treatment costs were CHF 193’000 ± 81’000 and abundance and phosphorylation within 1 hour after gavage. Similar to 242’000 ± 179’000 (p = 0.421) in the HCO and conventional dialyzer the high Pi diet in control mice, mice over expressing FGF23 or treated group, respectively. with recombinant FGF23 showed increased NCC abundance and Conclusions: Hemodialysis treatment with HCO membranes for cast phosphorylation. Also PTH stimulated NCC phosphorylation within nephropathy tended towards faster and better recovery of renal 45 min. However, while the high Pi diet stimulated phosphorylation function versus treatment with conventional dialyzers. However, no of SPAK, a positive regulator of NCC, isolated FGF23 overexpression statistically significant survival benefit could be detected for the HCO or administration did not stimulate SPAK phosphorylation, suggesting treatment group. Total medical costs were not higher in the group that high Pi intake and FGF23 activate NCC by distinct pathways. treated with HCO dialyzers despite the higher product price of the high However, genetic inactivation of SPAK prevented NCC cut-off membranes. phosphorylation. The expression of other Na+ transporters like NHE3, NKCC2 and ENaC remained unchanged. Conclusion: Dietary intake of Pi stimulates NCC activity and increases systolic blood pressure. The effect of Pi on NCC may involve several hormones such as PTH, FGF23 and aldosterone. OC 03 Long-term impact of cardio-renal invOlvement On adverse Background: Fabry disease (FD) is a rare X-linked lysosomal storage outcomes in patients with Fabry disease disease with a deficient activity of the enzyme alpha-galactosidase A Martin Siegenthaler1, Uyen Huynh-Do2, Urs Widmer3, which leads to progressive intralysosomal accumulation of Edouard Battegay1, Pierre-Alexandre Krayenbühl4, Albina Nowak1 globotriaosylceramide (GL-3) in different organs. We aimed to evaluate 1Department of Internal Medicine, University Hospital Zürich, Zürich; risk factors for the incidence of major cardiovascular complications and 2Department of Nephrology, Hypertension and Clinical Pharmacology, death in a prospective FD cohort. Inselspital, Bern University Hospital, Bern; 3Swiss Reinsurance Methods: A total of 104 genetically proven FD patients (mean age Company, Zürich; 4Department of Internal Medicine, Kantonsspital 45 ± 16; total males n = 40; on Enzyme replacement therapy (ERT) Uznach, Uznach 88% males, 45% females) were annually followed up at the University Figure 1: ROC-Curve of GFR an LVMMI to predict major cardiovascular events in patients with Morbus Fabry. GFR = glomerular filtration rate; LVMMI = left-ventricular yom cardial mass index; AUC = area under the curve SWISS MEDICAL WEEKLY 2015;145 (SUPPL 214) WWW.SMW.CH ORAL COMMUNICATIONS – CLINICAL NEPHROLOGY / HYPERTENSION / MINERAL / ELECTROLYTES 3 S Hospitals Zurich and Bern. The main outcome was a composite of OC 04 incident renal replacement therapy (RRT), stroke and death. Survival after acute kidney injury in patients Glomerular filtration rate (GFR) and left ventricular yom cardial mass with acute dyspnea index (LVMMI) where explored as the primary exposure variables. Results: During a median follow-up of 9 [5–12] years, 28 new events Tobias Breidthardt, Raphael Twerenbold, Zaid Sabti, Max Wagener, occurred in 25 patients: 11 died, 4 received RRT, 11 developed strokes, Christian Puelacher, Stefan Osswald, Christian
Load more

Recommended publications
  • Annual Report 2015/16
    ANNUAL REPORT 2015/16 EXPERTISE YOU CAN TRUST. HIRSLANDEN A MEDICLINIC INTERNATIONAL COMPANY 2 FINANCIAL YEAR AT A GLANCE THE HIRSLANDEN PRIVATE HOSPITAL GROUP IN FIGURES* 16 2,030 8,750 6,570 hospitals in 11 cantons affiliated and staff (without employed full-time jobs employed doctors doctors) 98,600 469,200 6,230 inpatients care days** newborns * Financial year 2015/16 ** based on midnight census, without newborns CONTENTS FINANCIAL YEAR PERFORMANCE Editorial 3 Financial year 2015/16 in figures 38 Interview with the Executive Committee 4 Range of services 39 End-of-year review 6 SwissDRG 40 Key data 8 Diagnoses and operations 42 Organisational structure 9 ICD and CHOP 43 Investments 10 Diagnosis related groups (DRG) in figures 44 HR Report 12 Specialties at each hospital 46 Health policy 13 Specialty: heart medicine 47 QUALITY REFERENCES Improving the quality of treatment 14 Infrastructure of the hospitals 48 Patient satisfaction 16 Glossary 50 Unplanned readmissions, unplanned Swiss sites 52 reoperations and falls 20 Strategic partnerships and company details 54 Infection monitoring and patient safety 24 Mortality in the intensive care unit 28 Quality medicine initiative 30 Peer review procedure 3 1 Comprehensive quality management system 34 CIRS 36 FINANCIAL YEAR 3 EDITORIAL DEAR HIRSLANDEN FRIENDS LADIES AND GENTLEMEN Throughout its history, the Hirslanden Private Hospital This results in a higher quality of care and added efficiency. Group has always adapted itself successfully to changes in We are also following this goal in our core business at the the healthcare system. In order for this to continue in the hospitals, where we are further refining the provision of our future, we have decided to make some changes to our stra­ services.
    [Show full text]
  • Blood Conservation Techniques and Perioperative Planning Part 7 May 2001
    Helping Hands for Blood Conservation Techniques and Perioperative Planning Part 7 May 2001 The List of Clinics with Special Blood Conservation Programs is by no means complete It does not take position as to the size of the clinic nor compare it with other clinics or make recommendations for some of them to be used in a special situation. Some of the clinics are small , others are big multidiciplinary Centers. But it tells us something about the special techniques used and the number of clinics using them , and it can help us to see where some of them can be found, and also gives an idea of the effectiveness of the methods. We doe not recommend any particular clinic nor doe we recommend any specific treatment. Table of Contents Table of Contents.............................................................................................................................................. 1 STARTING SPECIAL BLOOD CONSERVATION PROGRAMS ............................................................ 6 Introduction.................................................................................................................................................... 6 CLINICS WITH SPECIAL BLOOD CONSERVATION PROGRAMS .................................................. 10 1. AUSTRALIA............................................................................................................................................... 10 1) KALEEYA HOSPITAL MEDICAL CENTRE....................................................................................... 10 Fremantle
    [Show full text]
  • Expertise You Can Trust Hirslanden Private Hospital Group
    EXPERTISE YOU CAN TRUST HIRSLANDEN PRIVATE HOSPITAL GROUP 08/01/2020 Hirslanden Private Hospital Group 2 AGENDA 1 The Hirslanden Private Hospital Group 4 2 The Swiss public healthcare system 14 3 Hirslanden's fields of competence 17 4 Hirslanden's community involvement 22 08/01/2020 Hirslanden Private Hospital Group 3 AGENDA 1 The Hirslanden Private Hospital Group 4 2 The Swiss public healthcare system 14 3 Hirslanden's fields of competence 17 4 Hirslanden's community involvement 22 08/01/2020 Hirslanden Private Hospital Group 4 THE HIRSLANDEN PRIVATE HOSPITAL GROUP AT A GLANCE Key Figures 2018/19 Hospitals 17 in 10 Cantons Patient days2,3 479 631 Affiliated doctors 2 303 Newborns 6 742 Employees (including employed doctors) 10 442 Length of stay3 4.5 days Patients1 106 851 Turnover CHF 1 778 m Key Figures as of: 31 March 2019: 1 Inpatient admissions, without newborns / 2 Adult and maternity patients, source H+ / 3 Average in days, source H+ At a glance At 08/01/2020 Hirslanden Private Hospital Group 5 THE HIRSLANDEN PRIVATE HOSPITAL GROUP AT A GLANCE 21.8% Basic 48.7% Semi-private Private 29.5% At a glance At 08/01/2020 Hirslanden Private Hospital Group 6 THE HIRSLANDEN PRIVATE HOSPITAL GROUP 17 HOSPITALS BETWEEN CONSTANCE AND LAKE GENEVA geneva and lake constance 17 hospitals between 08/01/2020 Hirslanden Private Hospital Group 7 THE HIRSLANDEN PRIVATE HOSPITAL GROUP MEDICAL NETWORK 17 3 2 17 5 Hospitals Outpatient clinics day case clinics Radiology institutes Radiotherapy institutes Aarau Lausanne (2) Bern Lucerne Aarau Lucerne (2) Aarau Bern (3) Lucerne Schaffhausen Zurich Bern (2) Basle Geneva Biel Meggen Düdingen Biel Münchenstein Lausanne Cham Zug Basle Münchenstein Cham Zug St.
    [Show full text]
  • 2020 Clinical Services Report About This Report
    2020 CLINICAL SERVICES REPORT ABOUT THIS REPORT Mediclinic International plc (‘Mediclinic’ or the ‘Company’) is proud to publish a Clinical Services Report annually as part of a suite of reports in respect of both the 2019 calendar year and 2020 financial year. The reporting suite listed below is available on the Group’s website. • 2020 Annual Report and Financial Statements • 2020 Clinical Services Report • 2020 Sustainable Development Report • 2020 Notice of Annual General Meeting SCOPE The goal of this Report is to provide Mediclinic stakeholders with an overview of the most important clinical performance characteristics across its divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates (‘UAE’) (collectively, the ‘Group’) for the 2019 calendar year. Information is disclosed on a calendar year basis, unless stated otherwise. Mediclinic reports on its material issues at a Group level, but also discloses information on divisional initiatives and performance, as this is the level at which data is collected. This Report does not include information on initiatives undertaken by Spire Healthcare Group plc, a leading private healthcare group based in the United Kingdom and listed on the London Stock Exchange (‘LSE’), in which Mediclinic holds a 29.9% interest. COVID-19 It is also important to note that the COVID-19 pandemic falls outside this reporting period and will be discussed in detail in the 2021 Clinical Services Report. APPROVAL Mediclinic’s Clinical Performance and Sustainable Development Committee approved this Report on 13 May 2020. GLOSSARY OF TERMS Capitalised terms used in this Report are defined in the Glossary of terms on page 62.
    [Show full text]
  • Hirslanden Corporate Overview Presentation FY2017
    28.06.2017 1 EXPERTISE YOU CAN TRUST HIRSLANDEN PRIVATE HOSPITAL GROUP 28.06.2017 2 AGENDA I. The Hirslanden Private Hospital Group II. The Swiss public healthcare system III. Hirslanden’s fields of competence IV. Hirslanden’s community involvement 28.06.2017 3 I. THE HIRSLANDEN PRIVATE HOSPITAL GROUP 28.06.2017 4 VISION WE WILL BE RESPECTED THROUGHOUT SWITZERLAND. Because we deliver measurable top-quality medical outcomes, and concentrate all our activities on the needs of our patients. As the biggest provider of medical services, we unite all the relevant medical areas and the best doctors under one roof. All our activities are characterised by responsibility and sustainability. We thus guarantee long-term growth in Switzerland, and contribute towards Mediclinic International’s continuing growth as a successful international healthcare group. WE WILL BE PREFERRED LOCALLY. Because we deliver excellent patient care, our hospitals are firmly anchored in the local communities, and as an employer of choice we are able to provide qualified and loyal staff with professional challenge and development. We ensure aligned relationships with doctor communities, and build constructive relationships with all stakeholders. 28.06.2017 5 AT A GLANCE Key Figures 2016/17 Hospitals 16 in 11 Cantons Patient days1,2 466 025 Affiliated Doctors 1 708 Newborns 5 925 Employees 9 402 Length of stay3 4.6 days Patients1 100 293 Turnover CHF 1 704 m Key Figures as of 31 March 2017: 1 Inpatient admissions, without newborns / 2 Adult and maternity patients, source H+ / 3 Average in days, source H+ 28.06.2017 6 AT A GLANCE 24% Basic 45% Semi-private Private 31% 28.06.2017 7 16 HOSPITALS BETWEEN CONSTANCE AND LAKE GENEVA 28.06.2017 8 MEDICAL NETWORK 16 4 14 4 Hospitals Outpatient clinics Radiology institutes Radiotherapy institutes Aarau Meggen Lucerne Aarau Aarau Bern Basle Münchenstein Bern Bern (2) Lausanne Cham Zug Schaffhausen Schaffhausen Düdingen Männerdorf Geneva St.
    [Show full text]
  • Information Memorandum Relating to the Acquisition by Medi-Clinic of Hirslanden, a Private Hospital Group in Switzerland
    Information Memorandum relating to the acquisition by Medi-Clinic of Hirslanden, a private hospital group in Switzerland 1. Klinik Aarau 2. Klinik Hirslanden 3. Klinik Belair 3 2 1 13 4 13. Klinik Birshof 6 4. Klinik Am Rosenberg 12 5 11 7 10 9 8 12. Salem Spital 5. Andreas Klinik 11. Klinik Beau-Site 6. Klinik Im Park 10. Klinik Permanence 9. Clinique Bois-Cerf 8. Clinique Cecil 7. Klinik St. Anna Information Memorandum: Acquisition of Hirslanden by Medi-Clinic TABLE OF CONTENTS PAGE SECTION A – HIGHLIGHTS 1. Strategic rationale ....................................................................................................................................................................1 1.1. Introduction....................................................................................................................................................................1 1.2. The Hirslanden opportunity ...........................................................................................................................................1 1.3. Transformational acquisition..........................................................................................................................................1 2. Hirslanden.................................................................................................................................................................................2 2.1. Overview of Hirslanden .................................................................................................................................................2
    [Show full text]
  • Hirslanden 2016 Overview Presentation Vision
    HIRSLANDEN 2016 OVERVIEW PRESENTATION VISION WE WILL BE RESPECTED THROUGHOUT SWITZERLAND. Because we deliver measurable top-quality medical outcomes, and concentrate all our activities on the needs of our patients. As the biggest provider of medical services, we unite all the relevant medical areas and the best doctors under one roof. All our activities are characterised by responsibility and sustainability. We thus guarantee long-term growth in Switzerland, and contribute towards Mediclinic International’s continuing growth as a successful international healthcare group. WE WILL BE PREFERRED LOCALLY. Because we deliver excellent patient care, our hospitals are firmly anchored in the local communities, and as an employer of choice we are able to provide qualified and loyal staff with professional challenge and development. We ensure aligned relationships with doctor communities, and build constructive relationships with all stakeholders. EXECUTIVE COMMITTEE Dr Ole Wiesinger Dr Daniel Liedtke Dr Christian Westerhoff Andreas Kappeler Chief Executive Officer Chief Operating Officer Chief Clinical Officer Chief Financial Officer AT A GLANCE Hospitals 16 in 11 Cantons Patient days3,4 469 200 Doctors1 2 030 Newborns 6 230 Employees (without employed doctors) 8 750 Length of stay4 4.8 days Patients2 98 600 Turnover CHF 1 647 m Key Figures as of: 31 March 2016: 1 Affiliated and employed doctors / 2 Excl. doctors, 3 Inpatient admissions, without newborns / 4 Adult and maternity patients, source H+ / 5 Average in days, source H+ 16 HOSPITALS PATIENT MIX 25% Basic 43% Semi-private FY 2016 Private 32% MEDICAL NETWORK 16 4 14 4 Hospitals Outpatient clinics Radiology institutes Radiotherapy institutes Aarau Meggen Lucerne Aarau Aarau Bern Basle Münchenstein Bern Bern (2) Lausanne Cham Zug Schaffhausen Schaffhausen Düdingen Männerdorf Geneva St.
    [Show full text]
  • 滙豐自願醫保靈活計劃（鑽級） HSBC Voluntary Health Insurance Flexi Plan (Diamond Level)
    滙豐自願醫保靈活計劃（鑽級） HSBC Voluntary Health Insurance Flexi Plan (Diamond Level) 全球醫院名錄 Global Directory of Hospitals Notes ： 3. COUNTRY/REGION PROVIDER NAME PHONE NUMBER COUNTRY/REGION PROVIDER NAME PHONE NUMBER ALBANIA AMERICAN MEDICAL CENTER ARMENIA MOTHER AND CHILD REPUBLICAN MEDICAL ENDOCRINE CLINIC NEO STYLE CENTER GERMAN HOSPITAL NAIRI MEDICAL CENTER HYGEIA HOSPITAL TIRANA NATALY FARM MALATIA MEDICAL CENTER “PETRO NAKO” HOSPITAL OF SARANDA NATIONAL CENTER OF ONCOLOGY AFTER V A FANARJYAN QENDRA SHENDETESORE ABC CLINIC NORK MARASH MEDICAL CENTER SALUS SPITALI ITALIAN - TIRANA OPHTALMOLOGICAL CENTER AFTER SPITALI AMERIKAN – AMERICAN HOSPITAL SMALAYAN SPITALI AMERIKAN HOSPITAL 2 REPUBLICAN MEDICAL CENTER ARMENIA SPITALI AMERIKAN HOSPITAL 3 SCIENTIFIC CENTER OF TRAUMATOLOGY AND ALGERIA CLINIQUE AL AZHAR (213) 2329-0288 ORTHOPEDICS (NAUCHNIY CENTR CLINIQUE CHAHRAZED (213) 2136-2828 TRAVMATOLOGII I ORTOPEDII) CLINIQUE CHIFA HYDRA (213) 2353-1313 SEVAN HOSPITAL SLAVMED MEDICAL CENTER CLINIQUE EL BORDJ (213) 2120-5617 CLINIQUE MEDICALE AYA (213) 2357-8097 SURGERY CENTER AFTER A MIKAELYAN ANDORRA HOSPITAL NOSTRA SENYORA DE MERIXTELL YEREVAN STATE MEDICAL UNIVERSITY AFTER MKHITAR HERATSI ANGOLA CLIMED (2442) 2244-3514 CLINICA SAGRADA ESPERANCA (2449) 1250-1348 AUSTRALIA ALBANY HOSPITAL (618) 9892-2222 TOTAL CLINIC (2442) 2235-2633 ALBURY WODONGA PRIVATE HOSPITAL (612) 6041-1411 ALICE SPRINGS PUBLIC HOSPITAL (618) 8951-7777 ARGENTINA CLINICA DEL BOSQUE DE PINAMAR PRIEXEFED (5422) 5440-9490 S.R.L. ARMIDALE PRIVATE HOSPITAL (612) 6771-4000 CLINICA DEL
    [Show full text]
  • Hirslanden Quality Report 16/17
    QUALITY REPORT 2016/17 EXPERTISE YOU CAN TRUST. HIRSLANDEN A MEDICLINIC INTERNATIONAL COMPANY 2 FINANCIAL YEAR AT A GLANCE The Hirslanden Private Hospital Group in figures, as of 1 July 2017 17 2,000 9,920 hospitals in 11 cantons affiliated doctors staff with employed doctors As of 31 March 2017 100,293 466,025 5,952 inpatients care days * newborns * based on midnight census, without newborns CONTENTS QUALITY PERFORMANCE Quality at Hirslanden 4 Financial year 2016/17 in figures 30 Patient satisfaction 6 Range of services 31 Patient safety 10 SwissDRG 32 Quality medicine initiative 24 Diagnoses and operations 34 Peer review procedure 25 Diagnosis related groups (DRG) in figures 36 Comprehensive quality management system 28 REFERENCES Infrastructure of the hospitals 38 Glossary 40 Swiss sites 42 FINANCIAL YEAR 3 CONSOLIDATED FIGURES The most important consolidated figures for 2016/17 Change compared to 2014/15 2015/16 2016/17 2015/16 Patients Patients, maternity patients 1 94,037 98,609 100,293 2% Patient days 2 453,741 469,167 466,025 -1% Length of stay 4.8 4.8 4.6 -2% Turnover Turnover total (in CHF, millions) 1,563 1,647 1,704 3% Turnover inpatient services (in CHF, millions) 1,222 1,288 1,318 2% Turnover outpatient services (in CHF, millions) 262 275 300 9% Other operating income (in CHF, millions) 79 85 86 1% Number of employees Average FTEs 3 6,213 6,573 6,722 2% 1 Inpatient admissions, without newborns 2 Based on midnight census, without newborns 3 Apprentices, students and interns uniformly weighted, incl.
    [Show full text]
  • Annual Report 2014/15
    ANNUAL REPORT 2014/15 EXPERTISE YOU CAN TRUST. HIRSLANDEN PRIVATE HOSPITAL GROUP HIRSLANDEN A MEDICLINIC INTERNATIONAL COMPANY END-OF-YEAR REVIEW 2014/15 please fold out > 2014 APRIL MAY JUNE JULY KLINIK IM PARK CLINIQUE CECIL CLINIQUE BOIS-CERF KLINIK HIRSLANDEN Opening of the Vascular Clinique Cecil holds a Inauguration of the “Servan The new Practice for Per- Centre Im Park, a centre charity gala in collaboration 10” building on the hospi- sonalised Medicine investi- ofering the full range of with the “Une chance, tal premises, providing new gates whether and how modern vascular medicine. un cœur” foundation. The practice space for onco- well patients react to cer- event is a great success, logical/orthopaedic medi- tain medical substances. HIRSLANDEN BERNE with the proceeds helping cine and sports medicine The aim is to increase the Successful conclusion of to inance operations for and osteopathy specialists. safety and eiciency of the irst stage of the three people who are un- drug therapy by helping to Hirslanden Leuchtturm (HLT) able to receive treatment HIRSLANDEN KLINIK forgo inefective medica- project, providing a modern, in their own country. AARAU tion and minimise unwant- ICT-enhanced basis for Beginning of collaboration ed side-efects. medical core business and HIRSLANDEN KLINIK between Hirslanden Klinik administrative activities. AARAU Aarau and Aarau Cantonal KLINIK AM ROSENBERG Beginning of collaboration Hospital. This entails the Klinik Am Rosenberg KLINIK HIRSLANDEN between Hirslanden Klinik two hospitals co-operating strengthens its collabora- Opening of the Hirslanden Aarau and Inselspital Berne in the ield of heart medi- tion with the Appenzell Männedorf Institute of in the ield of heart surgery.
    [Show full text]